Literature DB >> 18189061

Pyoderma gangrenosum: dermatologic application of hyperbaric oxygen therapy.

William D Tutrone1, Kim Green, Jeffrey M Weinberg, Selin Caglar, Dick Clarke.   

Abstract

Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis of skin and subcutaneous tissue. The current accepted theory is that PG is an immunologic-based phenomenon. Several therapies have been used to control this disease, including corticosteroids, antibiotics, immunotherapy, dapsone, and hyperbaric oxygen therapy. This article will review the application of hyperbaric oxygen (HBO) therapy in patients with PG. Information for this manuscript was derived from multiple searches of MEDLINE and the National Baromedical Service literature collection. HBO therapy has been shown to effectively treat PG ulcers and reduce pain associated with PG in several case studies. Evidence from the studies cited herein help to establish a foundation for further research to investigate the role of HBO therapy as an adjuvant therapy in the treatment of PG.

Entities:  

Mesh:

Year:  2007        PMID: 18189061

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  6 in total

1.  Refractory postsurgical pyoderma gangrenosum in a patient with Beckwith Wiedemann syndrome: response to multimodal therapy.

Authors:  Faiza Fakhar; Sehrish Memon; Diane Deitz; Richard Abramowitz; Deborah R Alpert
Journal:  BMJ Case Rep       Date:  2013-10-23

2.  A favourable response to surgical intervention and hyperbaric oxygen therapy in pyoderma gangrenosum.

Authors:  Ilknur Altunay; Asli Kucukunal; Sezgi Sarikaya; Gulsen Tukenmez Demirci
Journal:  Int Wound J       Date:  2012-10-29       Impact factor: 3.315

3.  Pyoderma gangrenosum: A case report of bilateral dorsal hand lesions and literature review of management.

Authors:  Donald S Mowlds; Jeff J Kim; Patrick Murphy; Garrett A Wirth
Journal:  Can J Plast Surg       Date:  2013

4.  Pyoderma gangrenosum: skin grafting and hyperbaric oxygen as adjuvants in the treatment of a deep and extensive ulcer.

Authors:  Fernanda Mendes Araújo; Rogério Nabor Kondo; Lorivaldo Minelli
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

5.  Skin manifestations of inflammatory bowel disease.

Authors:  Brian L Huang; Stephanie Chandra; David Quan Shih
Journal:  Front Physiol       Date:  2012-02-06       Impact factor: 4.566

Review 6.  Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments.

Authors:  Carlo Alberto Maronese; Matthew A Pimentel; May M Li; Alex G Ortega-Loayza; Angelo Valerio Marzano; Giovanni Genovese
Journal:  Am J Clin Dermatol       Date:  2022-05-24       Impact factor: 6.233

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.